Cargando…
Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
SIMPLE SUMMARY: Brain cancers are a devastating disease with no cure. The aim of the study was to determine whether in vitro models can replace in vivo models to assess the brain permeability of novel drugs for brain cancer. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyse...
Autores principales: | Prashanth, Archana, Donaghy, Heather, Stoner, Shihani P., Hudson, Amanda L., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M., Grau, Georges E., McKelvey, Kelly J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956470/ https://www.ncbi.nlm.nih.gov/pubmed/33668807 http://dx.doi.org/10.3390/cancers13050955 |
Ejemplares similares
-
Differential effects of radiation fractionation regimens on glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2022) -
Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer
por: McKelvey, Kelly J., et al.
Publicado: (2020) -
Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2021) -
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
por: McKelvey, Kelly J., et al.
Publicado: (2020) -
Radiation, inflammation and the immune response in cancer
por: McKelvey, Kelly J., et al.
Publicado: (2018)